Similar articles

• Psychotic recurrence after antipsychotic discontinuation.

  Zipursky RB. Zipursky RB. Am J Psychiatry. 2002 Aug;159(8):1441-2; author reply 1442. doi: 10.1176/appi.ajp.159.8.1441-a. Am J Psychiatry. 2002. PMID: 12153856 No abstract available.
• Intermittent vs maintenance medication in schizophrenia. Two-year results.

  Herz MI, Glazer WM, Mostert MA, Sheard MA, Szymanski HV, Hafez H, Mirza M, Vana J. Herz MI, et al. Arch Gen Psychiatry. 1991 Apr;48(4):333-9. doi: 10.1001/archpsyc.1991.01810280049007. Arch Gen Psychiatry. 1991. PMID: 1672588 Clinical Trial.
• Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.

  Woods SW, Gueorguieva RV, Baker CB, Makuch RW. Woods SW, et al. Arch Gen Psychiatry. 2005 Sep;62(9):961-70. doi: 10.1001/archpsyc.62.9.961. Arch Gen Psychiatry. 2005. PMID: 16143728 Review.
• Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year.

  Jolley AG, Hirsch SR, McRink A, Manchanda R. Jolley AG, et al. BMJ. 1989 Apr 15;298(6679):985-90. doi: 10.1136/bmj.298.6679.985. BMJ. 1989. PMID: 2567190 Free PMC article. Clinical Trial.
• Antipsychotic medication: clinical guidelines for maintenance therapy.

  Johnson DA. Johnson DA. J Clin Psychiatry. 1985 May;46(5 Pt 2):6-15. J Clin Psychiatry. 1985. PMID: 2859281 Review.